Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome. / Pirhonen, Laura; Gyllensten, Hanna; Fors, Andreas; Bolin, Kristian.
In: European Journal of Health Economics, Vol. 21, No. 9, 2020, p. 1317-1327.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome
AU - Pirhonen, Laura
AU - Gyllensten, Hanna
AU - Fors, Andreas
AU - Bolin, Kristian
N1 - Publisher Copyright: © 2020, The Author(s).
PY - 2020
Y1 - 2020
N2 - Background: Person-centred care has been shown to be cost-effective compared to usual care for several diseases, including acute coronary syndrome, in a short-term time perspective (< 2 years). The cost-effectiveness of person-centred care in a longer time perspective is largely unknown. Objectives: To estimate the mid-term cost-effectiveness of person-centred care compared to usual care for patients (< 65) with acute coronary syndrome, using a 2-year and a 5-year time perspective. Methods: The mid-term cost-effectiveness of person-centred care compared to usual care was estimated by projecting the outcomes observed in a randomized-controlled trial together with data from health registers and data from the scientific literature, 3 years beyond the 2-year follow-up, using the developed simulation model. Probabilistic sensitivity analyses were performed using Monte Carlo simulation. Results: Person-centred care entails lower costs and improved effectiveness as compared to usual care, for a 2-year time and a 5-year perspective. Monte Carlo simulations suggest that the likelihoods of the person-centred care being cost-effective compared to usual care were between 80 and 99% and between 75 and 90% for a 2-year and a 5-year time perspective (using a 500,000 SEK/QALY willingness-to-pay threshold). Conclusions: Person-centred care was less costly and more effective compared to usual care in a 2-year and a 5-year time perspective for patients with acute coronary syndrome under the age of 65.
AB - Background: Person-centred care has been shown to be cost-effective compared to usual care for several diseases, including acute coronary syndrome, in a short-term time perspective (< 2 years). The cost-effectiveness of person-centred care in a longer time perspective is largely unknown. Objectives: To estimate the mid-term cost-effectiveness of person-centred care compared to usual care for patients (< 65) with acute coronary syndrome, using a 2-year and a 5-year time perspective. Methods: The mid-term cost-effectiveness of person-centred care compared to usual care was estimated by projecting the outcomes observed in a randomized-controlled trial together with data from health registers and data from the scientific literature, 3 years beyond the 2-year follow-up, using the developed simulation model. Probabilistic sensitivity analyses were performed using Monte Carlo simulation. Results: Person-centred care entails lower costs and improved effectiveness as compared to usual care, for a 2-year time and a 5-year perspective. Monte Carlo simulations suggest that the likelihoods of the person-centred care being cost-effective compared to usual care were between 80 and 99% and between 75 and 90% for a 2-year and a 5-year time perspective (using a 500,000 SEK/QALY willingness-to-pay threshold). Conclusions: Person-centred care was less costly and more effective compared to usual care in a 2-year and a 5-year time perspective for patients with acute coronary syndrome under the age of 65.
KW - Acute coronary syndrome
KW - Markov model
KW - Mid-term cost-effectiveness
KW - Person-centred care
KW - Randomized-controlled trial
U2 - 10.1007/s10198-020-01230-8
DO - 10.1007/s10198-020-01230-8
M3 - Journal article
C2 - 32895879
AN - SCOPUS:85090307900
VL - 21
SP - 1317
EP - 1327
JO - European Journal of Health Economics
JF - European Journal of Health Economics
SN - 1618-7598
IS - 9
ER -
ID: 391830398